Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Cachexia × Counseling × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3 Neoplasms 2 Fatigue 2 Tobacco Use Cessation 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Ovarian Neoplasms 1 Obesity 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Motor Activity 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Neutrophilic, Chronic 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1

Interventions

Megestrol Acetate 5 anamorelin 1 Standard of Care 1 Radiotherapy 1 Olanzapine 1 Melatonin 1 Infliximab 1 Ibuprofen 1 Etanercept 1 Eicosapentaenoic Acid 1 Docetaxel 1 Dietary Supplements 1 Cyproheptadine 1 Creatine 1 Counseling 1 Caseins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02330926 2025-08-29

MENAC

Norwegian University of Science and Technology

Phase 3 Completed

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡